Clinical trial
PRospective Multicenter Observational Study on Transfusion Practice in Vv-ECMO Patients: The PROTECMO Study
NCT03815773 is registered in ClinicalTrials.gov with The Mediterranean Institute for Transplantation and Advanced Specialized Therapies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PRospective Multicenter Observational Study on Transfusion Practice in Vv-ECMO Patients: The PROTECMO Study
- Lead sponsor
- The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2018
- Completion date
- December 31, 2020
- Enrollment
- 656 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulant-induced bleeding, extracorporeal membrane oxygenation complication, hemorrhage, transfusion related complication